Aromatase Inhibitor News and Research

RSS
Aromatase Inhibitors are drugs that prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy for postmenopausal women who have hormone-dependent breast cancer.
Aromatase inhibitors most effective in preventing breast cancer from coming back

Aromatase inhibitors most effective in preventing breast cancer from coming back

Estrogen therapy can help control metastatic breast cancer

Estrogen therapy can help control metastatic breast cancer

Anti-oestrogen drugs may promote more harmful cancer cell behaviour

Anti-oestrogen drugs may promote more harmful cancer cell behaviour

Study identifies causes of bone loss in breast cancer survivors

Study identifies causes of bone loss in breast cancer survivors

Breast and prostate cancer treatment may result in bone loss

Breast and prostate cancer treatment may result in bone loss

Unique genetic signature alerts physicians to high-risk breast tumors

Unique genetic signature alerts physicians to high-risk breast tumors

Seeking quality of life for cancer sufferers

Seeking quality of life for cancer sufferers

No link between aromatase inhibitors and cardiovascular problems

No link between aromatase inhibitors and cardiovascular problems

Global Alliance for Pharmacogenomics

Global Alliance for Pharmacogenomics

Late treatment with letrozole (Femara) can reduce breast cancer recurrence risk

Late treatment with letrozole (Femara) can reduce breast cancer recurrence risk

Femara helps protect against return of breast cancer after completing Tamoxifen therapy

Femara helps protect against return of breast cancer after completing Tamoxifen therapy

Study looks at denosumab in preventing bone loss caused by aromatase inhibitors

Study looks at denosumab in preventing bone loss caused by aromatase inhibitors

Discovery of novel mechanism to predict survival in older women with early stage lung cancer

Discovery of novel mechanism to predict survival in older women with early stage lung cancer

Breast cancer awareness calls for cardiovascular awareness

Breast cancer awareness calls for cardiovascular awareness

HER-2 status predicts success of chemotherapy in breast cancer treatment

HER-2 status predicts success of chemotherapy in breast cancer treatment

More research needed on sex differences in lung cancer

More research needed on sex differences in lung cancer

Risedronate prevents bone loss after breast cancer treatment

Risedronate prevents bone loss after breast cancer treatment

TFAP2C gene may be useful target for new breast cancer therapies

TFAP2C gene may be useful target for new breast cancer therapies

Some with breast cancer stop taking aromatase inhibitors because of joint and muscle pain

Some with breast cancer stop taking aromatase inhibitors because of joint and muscle pain

Latest drugs improve survival for metastatic breast cancer

Latest drugs improve survival for metastatic breast cancer